METTL3 and Alzheimer disease: This was accompanied by an increased level and redistribution of METTL3 expression in the AD hippocampus, likely representing aberrant misfolding and/or aggregation of METTL3, perhaps similar to the frequent aggregation of misfolded proteins in AD (Huang et al., 2020).